| 國立臺灣大學 |
1993 |
In Vitro Activity of Antimicrobial Agents, Alone and in Combination, Against Acinetobacter Baumannii Isolated from Blood
|
張上淳; 陳宜君; Luh, K. T.; 謝維銓; 張上淳; 陳宜君; Luh, K. T.; Hsieh, Wei-Chuan |
| 國立臺灣大學 |
2002-12 |
In vitro activity of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, SJ; Teng, LJ; Ho, SW; Luh, KT; Hsueh, PR. |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 嘉南藥理大學 |
2019 |
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
|
Lai, Chih-Cheng; Chen, Chi-Chung; Lu, Ying-Chen; Chuang, Yin-Ching; Tang, Hung-Jen |
| 國立成功大學 |
2020-04-1 |
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017)
|
Ko;Wen-Chien;Stone;Gregory, Gregory G. |
| 國立成功大學 |
2018 |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R. |
| 臺大學術典藏 |
2020-03-27T05:28:35Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-06T08:25:58Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO; Ko W.-C.; Wang F.-D.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺北醫學大學 |
1998 |
In vitro activity of ciprofloxacin against Mycobacterium tuberculosis
|
白冠壬; Ming-Chih Yu; Tzong-Fei Ong; Jen Suo; Kuan-Jen Bai; Tao-Ping Lin |
| 嘉南藥理大學 |
2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
|
Tang, Hung-Jen; Ku, Yee-Huang; Lee, Mei-Feng; Chuang, Yin-Ching; Yu, Wen-Liang |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020
|
Chang, Chang C.-Y.;Lee, Y.-L.;Huang, Y.-T.;Ko, W.-C.;Ho, M.-W.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020
|
Lee, Y.-L.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
|
Liu, Y.-M.;Ko, W.-C.;Ho, M.-W.;Lee, Y.-L.;Hsueh, P.-R. |
| 國家衛生研究院 |
2021-05-06 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
|
Kuo, SC;Wang, YC;Tan, MC;Huang, WC;Shiau, YR;Wang, HY;Lai, JF;Huang, IW;Lauderdale, TL |
| 高雄醫學大學 |
2009 |
In vitro Activity of Impatiens balsamina L. Against Multiple Antibiotic-Resistant Helicobacter pylori.
|
王苑春;吳登強;廖俊吉;吳政勳;李婉瑜;翁碧娟 ; Yuan-Chuen Wang;Deng-Chang Wu;Jyun-Ji Liao;Cheng-Hsun Wu;Wan-Yu Li;Bi-Chuang Weng |
| 臺大學術典藏 |
2018-09-10T06:16:32Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai, T.-Y. and Chang, S.-C. and Hsueh, P.-R. and Feng, N.-H. and Wang, J.-T.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:23Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Wang J.-T.;Feng N.-H.;PO-REN HSUEH;Chang S.-C.;Tsai T.-Y.; Tsai T.-Y.; Chang S.-C.; PO-REN HSUEH; Feng N.-H.; Wang J.-T. |
| 臺大學術典藏 |
2020-12-29T03:09:20Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Chang S.-C.; Hsueh P.-R.; Feng N.-H.; JANN-TAY WANG; Tsai T.-Y.;Chang S.-C.;Hsueh P.-R.;Feng N.-H.;Jann-Tay Wang; Tsai T.-Y. |
| 臺大學術典藏 |
2020-12-18T08:39:13Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai T.-Y.; Chang S.-C.; PO-REN HSUEH; Feng N.-H.; Wang J.-T. |
| 臺大學術典藏 |
2022-05-13T08:05:05Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai T.-Y.; Chang S.-C.; Hsueh P.-R.; Feng N.-H.; JANN-TAY WANG |
| 臺大學術典藏 |
2020-09-29T01:48:20Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang C.-T.;Chang S.-C.;Yee-Chun Chen;Hsieh S.-M.;Hsieh W.-C.; Fang C.-T.; Chang S.-C.; YEE-CHUN CHEN; Hsieh S.-M.; Hsieh W.-C. |
| 臺大學術典藏 |
2020-12-29T06:37:25Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang C.-T.; Chang S.-C.; Fang C.-T.;Chang S.-C.;Chen Y.-C.;Szu-Min Hsieh;Hsieh W.-C.; Chen Y.-C.; SZU-MIN HSIEH; Hsieh W.-C. |
| 臺大學術典藏 |
2020-12-30T02:43:37Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Hsieh S.-M.; Chen Y.-C.; SHAN-CHWEN CHANG; Fang C.-T.; Fang C.-T.;Shan-Chwen Chang;Chen Y.-C.;Hsieh S.-M.;Hsieh W.-C.; Hsieh W.-C. |
